Hedge Funds Are Betting On Amedisys Inc (AMED)

As one would reasonably expect, key money managers were breaking ground themselves. Highbridge Capital Management, managed by Glenn Russell Dubin, initiated the largest position in Amedisys Inc (NASDAQ:AMED). Highbridge Capital Management had $1.5 million invested in the company at the end of the quarter. Peter Algert and Kevin Coldiron’s Algert Coldiron Investors also initiated a $0.3 million position during the quarter. The following funds were also among the new Amedisys Inc (NASDAQ:AMED) investors: Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners, Paul Tudor Jones’ Tudor Investment Corp, and Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Amedisys Inc (NASDAQ:AMED) but similarly valued. These stocks are Alon USA Energy, Inc. (NYSE:ALJ), World Wrestling Entertainment, Inc. (NYSE:WWE), EP Energy Corp (NYSE:EPE), and HFF, Inc. (NYSE:HF). This group of stocks’ market values is closest to Amedisys Inc (NASDAQ:AMED)’s market value.

As you can see, these stocks had an average of 20 hedge funds with bullish positions and the average amount invested in these stocks was $108 million. That figure was $224 million in Amedisys Inc (NASDAQ:AMED)’s case. Alon USA Energy, Inc. (NYSE:ALJ) is the most popular stock in this table. On the other hand, HFF, Inc. (NYSE:HF) is the least popular one with only 18 bullish hedge fund positions. Compared to these stocks, Amedisys Inc (NASDAQ:AMED) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.